Okbah Mohamad1, Ali Zamlout1, Naseem AlKhoury2, Abd Aljawad Mazloum1, Marah Alsalkini3, Rafea Shaaban4. 1. Faculty of Medicine, Tishreen University, Latakia, Syria. 2. Faculty of Medicine, Tishreen University, Latakia, Syria. Naseem.AlKhoury@outlook.com. 3. Faculty of Medicine, Albaath University, Homs, Syria. 4. Faculty of Medicine, Al-Andalus University for Medical Sciences, Tartus, Syria.
Abstract
BACKGROUND AND OBJECTIVES: With global efforts to develop and deliver a COVID-19 vaccine rapidly, vaccine hesitancy stands as a barrier to these efforts. We aimed to estimate the proportion of Syrian adult population intending to be vaccinated against COVID-19 and, principally, to assess the demographic and attitudinal factors associated with it in order to approach suitable solutions. METHODS: An anonymous online questionnaire was conducted between 23rd December 2020 and 5th January 2021 in various provinces in Syria. A total of 3402 adults were sampled to reflect the population demographic factors. Attitudinal factors included Covid-19 fears, risks, and beliefs on the origin. Vaccination hesitancy and knowledge were also measured. The intention to get vaccinated against COVID-19 was the primary endpoint. RESULTS: According to their statements, 1222 participants (35.92%) will consent to get vaccinated against COVID-19. Our findings indicate that male gender, younger age, rural residence, not having children, smoking, fear about COVID-19, individual perceived severity, believing in the natural origin of the coronavirus, and high vaccination knowledge were positive predictors of embracing COVID-19 vaccine when it is available. CONCLUSION: COVID-19 vaccine acceptance rate is considerably poor across Syrian population compared to populations in developed countries. Vaccine hesitancy is closely bound to the fear of side effects and doubts about vaccine efficacy. Factors such as conspiracy beliefs and myths about the vaccine lower vaccine uptake. Thus, interventional educational campaigns are increasingly required to overcome misinformation and avert low vaccination acceptance rates.
BACKGROUND AND OBJECTIVES: With global efforts to develop and deliver a COVID-19 vaccine rapidly, vaccine hesitancy stands as a barrier to these efforts. We aimed to estimate the proportion of Syrian adult population intending to be vaccinated against COVID-19 and, principally, to assess the demographic and attitudinal factors associated with it in order to approach suitable solutions. METHODS: An anonymous online questionnaire was conducted between 23rd December 2020 and 5th January 2021 in various provinces in Syria. A total of 3402 adults were sampled to reflect the population demographic factors. Attitudinal factors included Covid-19 fears, risks, and beliefs on the origin. Vaccination hesitancy and knowledge were also measured. The intention to get vaccinated against COVID-19 was the primary endpoint. RESULTS: According to their statements, 1222 participants (35.92%) will consent to get vaccinated against COVID-19. Our findings indicate that male gender, younger age, rural residence, not having children, smoking, fear about COVID-19, individual perceived severity, believing in the natural origin of the coronavirus, and high vaccination knowledge were positive predictors of embracing COVID-19 vaccine when it is available. CONCLUSION:COVID-19 vaccine acceptance rate is considerably poor across Syrian population compared to populations in developed countries. Vaccine hesitancy is closely bound to the fear of side effects and doubts about vaccine efficacy. Factors such as conspiracy beliefs and myths about the vaccine lower vaccine uptake. Thus, interventional educational campaigns are increasingly required to overcome misinformation and avert low vaccination acceptance rates.
Authors: Antoine Garnier-Crussard; Emmanuel Forestier; Thomas Gilbert; Pierre Krolak-Salmon Journal: J Am Geriatr Soc Date: 2020-03-12 Impact factor: 5.562
Authors: Emily A Holmes; Rory C O'Connor; V Hugh Perry; Irene Tracey; Simon Wessely; Louise Arseneault; Clive Ballard; Helen Christensen; Roxane Cohen Silver; Ian Everall; Tamsin Ford; Ann John; Thomas Kabir; Kate King; Ira Madan; Susan Michie; Andrew K Przybylski; Roz Shafran; Angela Sweeney; Carol M Worthman; Lucy Yardley; Katherine Cowan; Claire Cope; Matthew Hotopf; Ed Bullmore Journal: Lancet Psychiatry Date: 2020-04-15 Impact factor: 27.083
Authors: Kailu Wang; Eliza Lai Yi Wong; Kin Fai Ho; Annie Wai Ling Cheung; Emily Ying Yang Chan; Eng Kiong Yeoh; Samuel Yeung Shan Wong Journal: Vaccine Date: 2020-09-10 Impact factor: 3.641
Authors: Ma'mon M Hatmal; Mohammad A I Al-Hatamleh; Amin N Olaimat; Rohimah Mohamud; Mirna Fawaz; Elham T Kateeb; Omar K Alkhairy; Reema Tayyem; Mohamed Lounis; Marwan Al-Raeei; Rasheed K Dana; Hamzeh J Al-Ameer; Mutasem O Taha; Khalid M Bindayna Journal: Vaccines (Basel) Date: 2022-02-26